[MDGL] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
06-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -8.78%
YoY- -151.75%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -49,023 -36,135 -27,740 -21,429 -19,699 -15,080 -11,475 163.52%
Tax -1,319 0 -28 0 0 0 -25 1310.10%
NP -49,023 -36,135 -27,740 -21,429 -19,699 -15,080 -11,475 163.52%
Tax Rate - - - - - - - -
Total Cost 49,023 36,135 27,740 21,429 19,699 15,080 11,475 163.52%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -3.18 -2.34 -1.80 -1.39 -1.28 -0.98 -0.75 162.19%
EPS Diluted -3.18 -2.34 -1.80 -1.39 -1.28 -0.98 -0.75 162.19%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.